
Two new appointments at Pharmalink Consulting
pharmafile | September 18, 2012 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Kevin Webb, Lorcan Flanagan, Pharmalink
Regulatory affairs specialists Pharmalink Consulting has announced two new appointments.
Lorcan Flanagan (pictured) joins as European Business Development manager and Kevin Webb as chief operating officer for the Americas.
Flanagan will be responsible for increasing the presence and profile of the company within Europe and building on Pharmalink’s regulatory consultancy solutions across the healthcare industry.
Flanagan will report to Kevin O’Toole, associate director, Commercial Operations. On his appointment O’Toole commented: “We are delighted that Lorcan has joined our team. His experience in delivering excellent customer care, his eye for detail and his friendly personality will ensure that he fits in perfectly to the Pharmalink team.”
Kevin Webb joins Pharmalink via internal promotion and becomes chief operating officer for the Americas. In his new role, Webb is responsible for the regulatory groups based at Pharmalink’s offices in Pennsylvania, Washington DC, San Juan Puerto Rico, San Diego and San Francisco CA.
Webb commented on his position: “I am excited that in this new role I will be able to develop our people in order to increase our scope of services to meet the ever increasing requirements of our customers”.






